New York

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• Bladder cancer1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial
• Prostate cancer1 trial
• Thyroid cancer1 trial
• Triple-negative breast cancer1 trial

Phase

• Phase 11 trial
• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Exelixis2 trials

Running trials

• Active, not recruiting

  Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer

  NCT05425940· Phase 3· Exelixis· Source

• Active, not recruiting

  Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

  NCT03170960· Phase 1· Exelixis· Source